Brand family
Pancreaze
United States
- Presentations
- 6
- Markets
- 1
Pancreaze is a brand of Pancrelipase amylase, Pancrelipase lipase and Pancrelipase protease marketed by Vivus, with 6 presentations listed and registered in United States. Each presentation below has its own page with packs, documents and availability for export supply from India.
- Active ingredient (INN)
- Pancrelipase amylase, Pancrelipase lipase and Pancrelipase protease
- Brand owner
- Vivus
- Registered in
- United States
- Strengths and forms
- 149900 units/37000 units/97300 units delayed-release capsule, 15200 units/2600 units/8800 units delayed-release capsule, 24600 units/4200 units/14200 units delayed-release capsule, 61500 units/10500 units/35500 units delayed-release capsule, 83900 units/21000 units/54700 units delayed-release capsule, 98400 units/16800 units/56800 units delayed-release capsule
All presentations
| Medicine | Manufacturer | Register | Availability |
|---|---|---|---|
| Pancreaze 149900 units/37000 units/97300 units delayed-release capsuleOral | Vivus | US FDA | Available on request |
| Pancreaze 15200 units/2600 units/8800 units delayed-release capsuleOral | Vivus | US FDA | Available on request |
| Pancreaze 24600 units/4200 units/14200 units delayed-release capsuleOral | Vivus | US FDA | Available on request |
| Pancreaze 61500 units/10500 units/35500 units delayed-release capsuleOral | Vivus | US FDA | Available on request |
| Pancreaze 83900 units/21000 units/54700 units delayed-release capsuleOral | Vivus | US FDA | Available on request |
| Pancreaze 98400 units/16800 units/56800 units delayed-release capsuleOral | Vivus | US FDA | Available on request |
Equivalent brands
Other brands of Pancrelipase amylase, Pancrelipase lipase and Pancrelipase protease.
Brand names and trademarks belong to their owners and are used only to identify products.
Request Pancreaze
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.